Search research articles
Contact Us
Filters
Showing results (241-250 of 263) with videos related to
Page
of 27
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 14, 2007
Refining the optimal chemotherapy regimen for good-risk metastatic nonseminomatous germ-cell tumors: a randomized trial of the Genito-Urinary Group of the French Federation of Cancer Centers (GETUG T93BP)
S Culine, P Kerbrat, A Kramar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1997
Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma: updated results of the prospective study LNH87-2. Groupe d'Etude des Lymphomes de l'Adulte
C Haioun, E Lepage, C Gisselbrecht, et al.
Presse Medicale (Paris, France : 1983)
|
October 25, 2000
[Standards, options and recommendations for good practice in hemoculture in cancerology]
V Bussy Malgrange, M P Blanc-Vincent, M C Escande, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 21, 1998
High-dose methotrexate for the treatment of primary cerebral lymphomas: analysis of survival and late neurologic toxicity in a retrospective series
J Y Blay, T Conroy, C Chevreau, et al.
Clinical Nutrition (Edinburgh, Scotland)
|
April 17, 1999
Energy expenditure during allogeneic and autologous bone marrow transplantation
V Chamouard Cogoluenhes, C Chambrier, M Michallet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 17, 2009
Long-term follow-up of an age-adapted C5R protocol followed by radiotherapy in 99 newly diagnosed primary CNS lymphomas: a prospective multicentric phase II study of the Groupe d'Etude des Lymphomes de l'Adulte (GELA)
H Ghesquières, C Ferlay, C Sebban, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 29, 2009
A risk model for severe anemia to select cancer patients for primary prophylaxis with epoetin alpha: a prospective randomized controlled trial of the ELYPSE study group
I Ray-Coquard, S Dussart, C Goillot, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 7, 2011
Autologous stem-cell transplantation in patients with mantle cell lymphoma beyond 65 years of age: a study from the European Group for Blood and Marrow Transplantation (EBMT)
E Jantunen, C Canals, M Attal, et al.
Bulletin Du Cancer
|
September 2, 2000
[Standards, Options and Recommendations (SOR) for the surveillance and the prevention of cross infections in oncology. Fédération Nationale des Centres de Lutte Contre le Cancer]
B Pottecher, R Herbrecht, M P Blanc-Vincent, et al.
Presse Medicale (Paris, France : 1983)
|
November 10, 2000
[Infection and cancer: general information and specific questions]
M Viot, M P Blanc-Vincent, J Béal, et al.
Page
of 27
Search research articles
Search
Showing results (241-250 of 263) with videos related to
Sort By:
Page
of 27
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 14, 2007
Refining the optimal chemotherapy regimen for good-risk metastatic nonseminomatous germ-cell tumors: a randomized trial of the Genito-Urinary Group of the French Federation of Cancer Centers (GETUG T93BP)
S Culine, P Kerbrat, A Kramar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1997
Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma: updated results of the prospective study LNH87-2. Groupe d'Etude des Lymphomes de l'Adulte
C Haioun, E Lepage, C Gisselbrecht, et al.
Presse Medicale (Paris, France : 1983)
|
October 25, 2000
[Standards, options and recommendations for good practice in hemoculture in cancerology]
V Bussy Malgrange, M P Blanc-Vincent, M C Escande, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 21, 1998
High-dose methotrexate for the treatment of primary cerebral lymphomas: analysis of survival and late neurologic toxicity in a retrospective series
J Y Blay, T Conroy, C Chevreau, et al.
Clinical Nutrition (Edinburgh, Scotland)
|
April 17, 1999
Energy expenditure during allogeneic and autologous bone marrow transplantation
V Chamouard Cogoluenhes, C Chambrier, M Michallet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 17, 2009
Long-term follow-up of an age-adapted C5R protocol followed by radiotherapy in 99 newly diagnosed primary CNS lymphomas: a prospective multicentric phase II study of the Groupe d'Etude des Lymphomes de l'Adulte (GELA)
H Ghesquières, C Ferlay, C Sebban, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 29, 2009
A risk model for severe anemia to select cancer patients for primary prophylaxis with epoetin alpha: a prospective randomized controlled trial of the ELYPSE study group
I Ray-Coquard, S Dussart, C Goillot, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 7, 2011
Autologous stem-cell transplantation in patients with mantle cell lymphoma beyond 65 years of age: a study from the European Group for Blood and Marrow Transplantation (EBMT)
E Jantunen, C Canals, M Attal, et al.
Bulletin Du Cancer
|
September 2, 2000
[Standards, Options and Recommendations (SOR) for the surveillance and the prevention of cross infections in oncology. Fédération Nationale des Centres de Lutte Contre le Cancer]
B Pottecher, R Herbrecht, M P Blanc-Vincent, et al.
Presse Medicale (Paris, France : 1983)
|
November 10, 2000
[Infection and cancer: general information and specific questions]
M Viot, M P Blanc-Vincent, J Béal, et al.
Page
of 27